

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.83240518 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.41426076 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.34764332 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.28162053 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.23591681 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.03350638 |
| 7 | vocalization behavior (GO:0071625) | 4.89516896 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.89426763 |
| 9 | glutamate secretion (GO:0014047) | 4.87162622 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.74106165 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.62915111 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 4.50308690 |
| 13 | protein localization to synapse (GO:0035418) | 4.48810397 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 4.47417866 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 4.42022416 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.32791635 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 4.29739671 |
| 18 | exploration behavior (GO:0035640) | 4.23056258 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.09601648 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.95081829 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.82810725 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.79941273 |
| 23 | neuronal action potential propagation (GO:0019227) | 3.74679878 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.71996860 |
| 25 | nucleobase catabolic process (GO:0046113) | 3.71766159 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.69703465 |
| 27 | proline transport (GO:0015824) | 3.68349679 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 3.62720773 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 3.61775188 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 3.59784573 |
| 31 | neuron recognition (GO:0008038) | 3.58151075 |
| 32 | dendrite morphogenesis (GO:0048813) | 3.57447477 |
| 33 | negative regulation of microtubule polymerization (GO:0031115) | 3.56402764 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 3.53511117 |
| 35 | positive regulation of synapse maturation (GO:0090129) | 3.53485690 |
| 36 | activation of protein kinase A activity (GO:0034199) | 3.53139225 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.50255633 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48619630 |
| 39 | detection of calcium ion (GO:0005513) | 3.48613989 |
| 40 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46926842 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.44225115 |
| 42 | response to pheromone (GO:0019236) | 3.43918107 |
| 43 | postsynaptic membrane organization (GO:0001941) | 3.38970552 |
| 44 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.36611779 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.35850139 |
| 46 | long-term memory (GO:0007616) | 3.34553995 |
| 47 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.32849467 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.31392299 |
| 49 | axonal fasciculation (GO:0007413) | 3.30836161 |
| 50 | sodium ion export (GO:0071436) | 3.30122318 |
| 51 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.29124217 |
| 52 | neurotransmitter transport (GO:0006836) | 3.28940258 |
| 53 | cell migration in hindbrain (GO:0021535) | 3.26584499 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25908814 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.25895630 |
| 56 | protein K11-linked deubiquitination (GO:0035871) | 3.25317515 |
| 57 | serotonin receptor signaling pathway (GO:0007210) | 3.20380039 |
| 58 | cell communication by electrical coupling (GO:0010644) | 3.19382888 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.17060056 |
| 60 | auditory behavior (GO:0031223) | 3.16385870 |
| 61 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.15023457 |
| 62 | cerebellar granule cell differentiation (GO:0021707) | 3.14447245 |
| 63 | regulation of synaptic plasticity (GO:0048167) | 3.11507684 |
| 64 | neuromuscular process controlling balance (GO:0050885) | 3.11384534 |
| 65 | response to auditory stimulus (GO:0010996) | 3.09050572 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03994262 |
| 67 | regulation of vesicle fusion (GO:0031338) | 3.02757040 |
| 68 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01691793 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.01647535 |
| 70 | organelle transport along microtubule (GO:0072384) | 3.00968007 |
| 71 | startle response (GO:0001964) | 3.00903901 |
| 72 | regulation of neurotransmitter transport (GO:0051588) | 3.00867111 |
| 73 | long-term synaptic potentiation (GO:0060291) | 3.00673853 |
| 74 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.00625025 |
| 75 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99803902 |
| 76 | synapse assembly (GO:0007416) | 2.98473772 |
| 77 | membrane depolarization during action potential (GO:0086010) | 2.98100423 |
| 78 | glycosphingolipid biosynthetic process (GO:0006688) | 2.97613311 |
| 79 | vesicle transport along microtubule (GO:0047496) | 2.96534971 |
| 80 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.96532095 |
| 81 | neurofilament cytoskeleton organization (GO:0060052) | 2.96435014 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96377246 |
| 83 | transmission of nerve impulse (GO:0019226) | 2.94828824 |
| 84 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94702097 |
| 85 | membrane hyperpolarization (GO:0060081) | 2.94195646 |
| 86 | axon cargo transport (GO:0008088) | 2.93803378 |
| 87 | axon ensheathment in central nervous system (GO:0032291) | 2.93384732 |
| 88 | central nervous system myelination (GO:0022010) | 2.93384732 |
| 89 | activated T cell proliferation (GO:0050798) | 2.93059520 |
| 90 | neuromuscular process controlling posture (GO:0050884) | 2.92113874 |
| 91 | presynaptic membrane assembly (GO:0097105) | 2.92111055 |
| 92 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.90794598 |
| 93 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.90087199 |
| 94 | neuronal ion channel clustering (GO:0045161) | 2.88988849 |
| 95 | membrane depolarization (GO:0051899) | 2.87960372 |
| 96 | innervation (GO:0060384) | 2.87837928 |
| 97 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87587733 |
| 98 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.87086606 |
| 99 | synaptic transmission (GO:0007268) | 2.85039453 |
| 100 | presynaptic membrane organization (GO:0097090) | 2.84172009 |
| 101 | nerve growth factor signaling pathway (GO:0038180) | 2.82302128 |
| 102 | positive regulation of neurotransmitter transport (GO:0051590) | 2.82052277 |
| 103 | synaptic vesicle transport (GO:0048489) | 2.81994206 |
| 104 | establishment of synaptic vesicle localization (GO:0097480) | 2.81994206 |
| 105 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.81663520 |
| 106 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.81240369 |
| 107 | neuromuscular synaptic transmission (GO:0007274) | 2.81180314 |
| 108 | establishment of mitochondrion localization (GO:0051654) | 2.80475566 |
| 109 | neurotransmitter uptake (GO:0001504) | 2.80139709 |
| 110 | regulation of synapse maturation (GO:0090128) | 2.79780915 |
| 111 | glycine transport (GO:0015816) | 2.79745912 |
| 112 | clathrin coat assembly (GO:0048268) | 2.79546815 |
| 113 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.79189513 |
| 114 | dopamine receptor signaling pathway (GO:0007212) | 2.78782967 |
| 115 | regulation of ARF protein signal transduction (GO:0032012) | 2.78741223 |
| 116 | adult walking behavior (GO:0007628) | 2.76654227 |
| 117 | response to amphetamine (GO:0001975) | 2.73162592 |
| 118 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.71258417 |
| 119 | glycerophospholipid catabolic process (GO:0046475) | 2.70830069 |
| 120 | potassium ion import (GO:0010107) | 2.70781639 |
| 121 | negative regulation of heart rate (GO:0010459) | 2.69363508 |
| 122 | vesicle docking involved in exocytosis (GO:0006904) | 2.66665451 |
| 123 | neuronal action potential (GO:0019228) | 2.65867303 |
| 124 | mechanosensory behavior (GO:0007638) | 2.60110306 |
| 125 | positive regulation of dendritic spine development (GO:0060999) | 2.59478980 |
| 126 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.55381424 |
| 127 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.54006725 |
| 128 | potassium ion homeostasis (GO:0055075) | 2.53448593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.01884594 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45677333 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07203553 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99282381 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96211502 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75425648 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65087660 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65087660 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54232941 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50094407 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50082540 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49467667 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.49403499 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48092611 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47166838 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46009792 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44278075 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31676182 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28005636 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24234904 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.24132152 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.22518859 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16057771 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.13765506 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07796566 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.01661892 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96555712 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94508363 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93539540 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91609176 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.71806492 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68723188 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60086122 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56334916 |
| 35 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53258086 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52952295 |
| 37 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.50913930 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42953335 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40227703 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39480182 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38642010 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37851146 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36973119 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32754741 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32640186 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32034644 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31925020 |
| 48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31888983 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30515607 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28735993 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28522822 |
| 52 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28041916 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27355468 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26737514 |
| 55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26471193 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26382238 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26231123 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25556134 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25523094 |
| 60 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.25409910 |
| 61 | * AR_19668381_ChIP-Seq_PC3_Human | 1.24592825 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23726915 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22474031 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21534924 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20060670 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19852625 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18774485 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17585420 |
| 69 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17473545 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17120878 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17054525 |
| 72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16471594 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15751357 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15581918 |
| 75 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13892588 |
| 76 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.13819447 |
| 77 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12515366 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11791570 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.11657347 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10892962 |
| 81 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10844994 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10257252 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10257252 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09259640 |
| 85 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08529825 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07385772 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07192894 |
| 88 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06616382 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05906030 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05595637 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.05184191 |
| 92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04017601 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03837862 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03612999 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03416478 |
| 96 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03013465 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02210540 |
| 98 | JUN_21703547_ChIP-Seq_K562_Human | 1.02064217 |
| 99 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01323246 |
| 100 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01292761 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01086858 |
| 102 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99717719 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99596909 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99197718 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99004472 |
| 106 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98439269 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98385031 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98175114 |
| 109 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97615763 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97489773 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96905162 |
| 112 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96781068 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96693708 |
| 114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96472942 |
| 115 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96442650 |
| 116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96383946 |
| 117 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.95076512 |
| 118 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94794901 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92701429 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92468758 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92245689 |
| 122 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92015444 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90870788 |
| 124 | * EWS_26573619_Chip-Seq_HEK293_Human | 0.90799923 |
| 125 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90731156 |
| 126 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90580309 |
| 127 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89035839 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86583430 |
| 129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86583430 |
| 130 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85756939 |
| 131 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85561769 |
| 132 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83179476 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82485646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.88000935 |
| 2 | MP0003880_abnormal_central_pattern | 4.20431726 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.92445454 |
| 4 | MP0004270_analgesia | 3.91546925 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.17163826 |
| 6 | MP0009745_abnormal_behavioral_response | 3.04023313 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.96148151 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.94907648 |
| 9 | MP0002064_seizures | 2.91228274 |
| 10 | MP0009046_muscle_twitch | 2.88046669 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.78308211 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.61253943 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.46317519 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.44389385 |
| 15 | MP0002272_abnormal_nervous_system | 2.41926595 |
| 16 | MP0001486_abnormal_startle_reflex | 2.35298215 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.29312133 |
| 18 | MP0002736_abnormal_nociception_after | 2.24117316 |
| 19 | MP0001970_abnormal_pain_threshold | 2.11770463 |
| 20 | MP0000778_abnormal_nervous_system | 2.08576759 |
| 21 | MP0004858_abnormal_nervous_system | 2.04440829 |
| 22 | MP0002822_catalepsy | 2.04418796 |
| 23 | MP0003329_amyloid_beta_deposits | 2.03820624 |
| 24 | MP0002184_abnormal_innervation | 1.98415857 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.98015290 |
| 26 | MP0008569_lethality_at_weaning | 1.97422877 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.94246397 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.91314362 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.90373901 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.90072147 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.84469488 |
| 32 | MP0004924_abnormal_behavior | 1.80985668 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.80985668 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.79357899 |
| 35 | MP0000955_abnormal_spinal_cord | 1.69718578 |
| 36 | MP0001984_abnormal_olfaction | 1.69405623 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.64108284 |
| 38 | MP0002882_abnormal_neuron_morphology | 1.51811204 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.50223024 |
| 40 | MP0003122_maternal_imprinting | 1.49474051 |
| 41 | MP0003787_abnormal_imprinting | 1.47294068 |
| 42 | MP0001529_abnormal_vocalization | 1.46692519 |
| 43 | MP0004885_abnormal_endolymph | 1.41512175 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.40567108 |
| 45 | MP0003633_abnormal_nervous_system | 1.32213362 |
| 46 | MP0000751_myopathy | 1.29465556 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.27597023 |
| 48 | MP0002102_abnormal_ear_morphology | 1.27574606 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.27099882 |
| 50 | MP0003879_abnormal_hair_cell | 1.25312073 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.25217114 |
| 52 | MP0004147_increased_porphyrin_level | 1.23223848 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.22933714 |
| 54 | MP0003121_genomic_imprinting | 1.19798406 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.17337052 |
| 56 | MP0001905_abnormal_dopamine_level | 1.16546978 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.16003263 |
| 58 | MP0002152_abnormal_brain_morphology | 1.14912030 |
| 59 | MP0004142_abnormal_muscle_tone | 1.14277315 |
| 60 | MP0003631_nervous_system_phenotype | 1.13544198 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.11846667 |
| 62 | MP0002229_neurodegeneration | 1.10196872 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.09588252 |
| 64 | MP0001188_hyperpigmentation | 1.06261570 |
| 65 | MP0004215_abnormal_myocardial_fiber | 1.05252929 |
| 66 | MP0003634_abnormal_glial_cell | 1.01542071 |
| 67 | MP0004085_abnormal_heartbeat | 0.97772181 |
| 68 | MP0002638_abnormal_pupillary_reflex | 0.97420828 |
| 69 | MP0000013_abnormal_adipose_tissue | 0.97004852 |
| 70 | MP0003724_increased_susceptibility_to | 0.94181472 |
| 71 | MP0005394_taste/olfaction_phenotype | 0.94171613 |
| 72 | MP0005499_abnormal_olfactory_system | 0.94171613 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.92320738 |
| 74 | MP0000920_abnormal_myelination | 0.92169428 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.91280788 |
| 76 | MP0000604_amyloidosis | 0.91016405 |
| 77 | MP0004742_abnormal_vestibular_system | 0.88535460 |
| 78 | MP0002069_abnormal_eating/drinking_beha | 0.87156529 |
| 79 | MP0003137_abnormal_impulse_conducting | 0.86074366 |
| 80 | MP0002752_abnormal_somatic_nervous | 0.84964628 |
| 81 | MP0004233_abnormal_muscle_weight | 0.83778610 |
| 82 | MP0003632_abnormal_nervous_system | 0.82692954 |
| 83 | MP0004130_abnormal_muscle_cell | 0.80673353 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.79601839 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.79026289 |
| 86 | MP0002090_abnormal_vision | 0.78132136 |
| 87 | MP0004510_myositis | 0.78130882 |
| 88 | MP0005253_abnormal_eye_physiology | 0.77685230 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.77584723 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.76158992 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.74734351 |
| 92 | MP0003283_abnormal_digestive_organ | 0.73907911 |
| 93 | MP0005535_abnormal_body_temperature | 0.73432242 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.72672898 |
| 95 | MP0004484_altered_response_of | 0.72634280 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.71794113 |
| 97 | MP0008874_decreased_physiological_sensi | 0.71603630 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.71442762 |
| 99 | MP0003646_muscle_fatigue | 0.71201495 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.69952740 |
| 101 | MP0003690_abnormal_glial_cell | 0.67895910 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.67014091 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.65477243 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.65352682 |
| 105 | MP0005187_abnormal_penis_morphology | 0.65310764 |
| 106 | MP0008872_abnormal_physiological_respon | 0.64074293 |
| 107 | MP0003075_altered_response_to | 0.63959599 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.62755129 |
| 109 | MP0003861_abnormal_nervous_system | 0.62471339 |
| 110 | MP0001177_atelectasis | 0.62013823 |
| 111 | MP0005409_darkened_coat_color | 0.61849906 |
| 112 | MP0004043_abnormal_pH_regulation | 0.61730029 |
| 113 | MP0004036_abnormal_muscle_relaxation | 0.60347264 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.59990934 |
| 115 | MP0002653_abnormal_ependyma_morphology | 0.58558711 |
| 116 | MP0005670_abnormal_white_adipose | 0.57682707 |
| 117 | MP0005671_abnormal_response_to | 0.56274792 |
| 118 | MP0008775_abnormal_heart_ventricle | 0.56097866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.77679039 |
| 2 | Focal motor seizures (HP:0011153) | 5.76117927 |
| 3 | Visual hallucinations (HP:0002367) | 4.85596280 |
| 4 | Focal seizures (HP:0007359) | 4.83159006 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.34790300 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.09234266 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.99317758 |
| 8 | Atonic seizures (HP:0010819) | 3.87833073 |
| 9 | Action tremor (HP:0002345) | 3.76694340 |
| 10 | Ankle clonus (HP:0011448) | 3.73323974 |
| 11 | Mutism (HP:0002300) | 3.69135656 |
| 12 | Febrile seizures (HP:0002373) | 3.68488831 |
| 13 | Absence seizures (HP:0002121) | 3.42817216 |
| 14 | Pheochromocytoma (HP:0002666) | 3.29745427 |
| 15 | Broad-based gait (HP:0002136) | 3.25084093 |
| 16 | Papilledema (HP:0001085) | 3.23462118 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.21705873 |
| 18 | Depression (HP:0000716) | 3.16869455 |
| 19 | Poor eye contact (HP:0000817) | 3.15973006 |
| 20 | Dialeptic seizures (HP:0011146) | 3.14171786 |
| 21 | Limb dystonia (HP:0002451) | 3.08371428 |
| 22 | Abnormal eating behavior (HP:0100738) | 3.05486217 |
| 23 | Truncal ataxia (HP:0002078) | 3.02171064 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.89585941 |
| 25 | Termporal pattern (HP:0011008) | 2.88177852 |
| 26 | Insidious onset (HP:0003587) | 2.88177852 |
| 27 | Neurofibrillary tangles (HP:0002185) | 2.86737606 |
| 28 | Abnormality of the corticospinal tract (HP:0002492) | 2.86477801 |
| 29 | Anxiety (HP:0000739) | 2.84127386 |
| 30 | Neuroendocrine neoplasm (HP:0100634) | 2.83563759 |
| 31 | Genetic anticipation (HP:0003743) | 2.83031805 |
| 32 | Abnormal social behavior (HP:0012433) | 2.82826888 |
| 33 | Impaired social interactions (HP:0000735) | 2.82826888 |
| 34 | Polyphagia (HP:0002591) | 2.81297956 |
| 35 | Dysmetria (HP:0001310) | 2.79480118 |
| 36 | Agitation (HP:0000713) | 2.75585357 |
| 37 | Excessive salivation (HP:0003781) | 2.75209635 |
| 38 | Drooling (HP:0002307) | 2.75209635 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 2.73954336 |
| 40 | Hyperventilation (HP:0002883) | 2.73623205 |
| 41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.73513034 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.71799637 |
| 43 | Amyotrophic lateral sclerosis (HP:0007354) | 2.68618759 |
| 44 | Urinary urgency (HP:0000012) | 2.68481581 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.62713411 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.62638302 |
| 47 | Diplopia (HP:0000651) | 2.62638302 |
| 48 | Spastic gait (HP:0002064) | 2.62291047 |
| 49 | Progressive inability to walk (HP:0002505) | 2.61863589 |
| 50 | Torticollis (HP:0000473) | 2.53672698 |
| 51 | Stereotypic behavior (HP:0000733) | 2.49789741 |
| 52 | Postural instability (HP:0002172) | 2.48698487 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.47221959 |
| 54 | Amblyopia (HP:0000646) | 2.44378659 |
| 55 | Cerebral hypomyelination (HP:0006808) | 2.42685428 |
| 56 | Epileptiform EEG discharges (HP:0011182) | 2.40532566 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.39938013 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.38183985 |
| 59 | Lower limb muscle weakness (HP:0007340) | 2.36499604 |
| 60 | Scanning speech (HP:0002168) | 2.34770618 |
| 61 | Hemiparesis (HP:0001269) | 2.34420946 |
| 62 | Spastic tetraplegia (HP:0002510) | 2.30398191 |
| 63 | Hypsarrhythmia (HP:0002521) | 2.29940953 |
| 64 | Peripheral hypomyelination (HP:0007182) | 2.29486473 |
| 65 | Abnormality of the lower motor neuron (HP:0002366) | 2.26687812 |
| 66 | Apathy (HP:0000741) | 2.26133683 |
| 67 | Focal dystonia (HP:0004373) | 2.25469951 |
| 68 | Inappropriate behavior (HP:0000719) | 2.23867833 |
| 69 | Megalencephaly (HP:0001355) | 2.23248967 |
| 70 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.18593534 |
| 71 | Intention tremor (HP:0002080) | 2.17261475 |
| 72 | Ventricular fibrillation (HP:0001663) | 2.15502352 |
| 73 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.14717544 |
| 74 | Delusions (HP:0000746) | 2.13882711 |
| 75 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.09293551 |
| 76 | Hypoplasia of the brainstem (HP:0002365) | 2.09293551 |
| 77 | Dysmetric saccades (HP:0000641) | 2.08992407 |
| 78 | Bradykinesia (HP:0002067) | 2.07931323 |
| 79 | Craniofacial dystonia (HP:0012179) | 2.06919460 |
| 80 | Absent speech (HP:0001344) | 2.06887530 |
| 81 | Akinesia (HP:0002304) | 2.06596716 |
| 82 | Clonus (HP:0002169) | 2.05362980 |
| 83 | Hemiplegia (HP:0002301) | 2.04659920 |
| 84 | Status epilepticus (HP:0002133) | 2.04499366 |
| 85 | Failure to thrive in infancy (HP:0001531) | 2.03605917 |
| 86 | Inability to walk (HP:0002540) | 2.03579660 |
| 87 | Fetal akinesia sequence (HP:0001989) | 2.02944234 |
| 88 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.02904275 |
| 89 | Medial flaring of the eyebrow (HP:0010747) | 2.02565615 |
| 90 | Central scotoma (HP:0000603) | 2.01212974 |
| 91 | Diminished motivation (HP:0000745) | 2.01125795 |
| 92 | Renal cortical cysts (HP:0000803) | 2.00937825 |
| 93 | Prolonged QT interval (HP:0001657) | 1.99843136 |
| 94 | Gait imbalance (HP:0002141) | 1.98296190 |
| 95 | Syncope (HP:0001279) | 1.97942592 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 1.97695705 |
| 97 | Tetraplegia (HP:0002445) | 1.97534236 |
| 98 | Obstructive sleep apnea (HP:0002870) | 1.97090100 |
| 99 | Abnormal EKG (HP:0003115) | 1.96863762 |
| 100 | Muscular hypotonia of the trunk (HP:0008936) | 1.95692248 |
| 101 | Hypothermia (HP:0002045) | 1.94115543 |
| 102 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.93925035 |
| 103 | Nephrogenic diabetes insipidus (HP:0009806) | 1.93542154 |
| 104 | Congenital primary aphakia (HP:0007707) | 1.92183946 |
| 105 | Specific learning disability (HP:0001328) | 1.90263876 |
| 106 | Bundle branch block (HP:0011710) | 1.89411593 |
| 107 | Abnormality of salivation (HP:0100755) | 1.89087279 |
| 108 | Insomnia (HP:0100785) | 1.89037720 |
| 109 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88318072 |
| 110 | Impaired vibratory sensation (HP:0002495) | 1.88208553 |
| 111 | Abnormality of the labia minora (HP:0012880) | 1.86514918 |
| 112 | Gait ataxia (HP:0002066) | 1.83955599 |
| 113 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.83913310 |
| 114 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.83913310 |
| 115 | Lissencephaly (HP:0001339) | 1.83796395 |
| 116 | Postural tremor (HP:0002174) | 1.81998636 |
| 117 | Rapidly progressive (HP:0003678) | 1.81967842 |
| 118 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81450312 |
| 119 | Psychosis (HP:0000709) | 1.80681843 |
| 120 | Sleep apnea (HP:0010535) | 1.79744162 |
| 121 | CNS hypomyelination (HP:0003429) | 1.79405824 |
| 122 | Autoamputation (HP:0001218) | 1.77236625 |
| 123 | Pachygyria (HP:0001302) | 1.77186284 |
| 124 | Paraplegia (HP:0010550) | 1.75507252 |
| 125 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.73736313 |
| 126 | Hypoplasia of the corpus callosum (HP:0002079) | 1.73536513 |
| 127 | Poor suck (HP:0002033) | 1.68695168 |
| 128 | Sudden death (HP:0001699) | 1.68616005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.87939295 |
| 2 | MAP3K9 | 3.75283922 |
| 3 | NTRK3 | 3.62703583 |
| 4 | MINK1 | 3.00628133 |
| 5 | MAP3K4 | 2.99591397 |
| 6 | EPHA4 | 2.75125763 |
| 7 | TXK | 2.65269201 |
| 8 | MAP2K7 | 2.55548629 |
| 9 | MAP4K2 | 2.40299421 |
| 10 | NTRK2 | 2.21153483 |
| 11 | PAK6 | 2.19910151 |
| 12 | FRK | 2.15536142 |
| 13 | DAPK2 | 2.13965942 |
| 14 | MAP3K12 | 2.03626465 |
| 15 | NTRK1 | 2.01351722 |
| 16 | CASK | 1.90994528 |
| 17 | KSR2 | 1.88174756 |
| 18 | MAPK13 | 1.87418708 |
| 19 | PHKG2 | 1.86721833 |
| 20 | PHKG1 | 1.86721833 |
| 21 | CAMKK1 | 1.74851639 |
| 22 | MAP2K4 | 1.74728936 |
| 23 | PRKD3 | 1.64969423 |
| 24 | CDK5 | 1.58779699 |
| 25 | EPHA3 | 1.58500669 |
| 26 | TAOK3 | 1.55744296 |
| 27 | KSR1 | 1.50262412 |
| 28 | TRIM28 | 1.49742596 |
| 29 | PLK2 | 1.49016484 |
| 30 | UHMK1 | 1.47619223 |
| 31 | CAMKK2 | 1.46225154 |
| 32 | DAPK1 | 1.36321805 |
| 33 | CDK19 | 1.30207638 |
| 34 | SIK2 | 1.29026898 |
| 35 | TNIK | 1.23018777 |
| 36 | GRK5 | 1.16593930 |
| 37 | LATS2 | 1.15587308 |
| 38 | SGK494 | 1.13922650 |
| 39 | SGK223 | 1.13922650 |
| 40 | PRPF4B | 1.11061060 |
| 41 | PRKCG | 1.08877423 |
| 42 | RIPK4 | 1.04960193 |
| 43 | FES | 1.04924258 |
| 44 | LMTK2 | 1.04438033 |
| 45 | CDK14 | 1.02306381 |
| 46 | DYRK2 | 1.02043038 |
| 47 | RET | 1.00652459 |
| 48 | MAP3K2 | 0.98911185 |
| 49 | CDK18 | 0.98735310 |
| 50 | CSNK1A1L | 0.98240813 |
| 51 | MARK2 | 0.95372749 |
| 52 | CDK15 | 0.94568074 |
| 53 | TAOK1 | 0.94462460 |
| 54 | ARAF | 0.90353305 |
| 55 | PAK3 | 0.90329869 |
| 56 | TYRO3 | 0.89801649 |
| 57 | CSNK1G1 | 0.89713584 |
| 58 | SYK | 0.89545330 |
| 59 | ITK | 0.88060016 |
| 60 | PRKCH | 0.87791191 |
| 61 | CSNK1G2 | 0.87279410 |
| 62 | CAMK2A | 0.86881802 |
| 63 | STK38 | 0.85479529 |
| 64 | SIK3 | 0.83668994 |
| 65 | FER | 0.83658799 |
| 66 | ADRBK2 | 0.81809531 |
| 67 | CDK11A | 0.81248609 |
| 68 | SGK2 | 0.79461163 |
| 69 | DYRK1A | 0.78638995 |
| 70 | LIMK1 | 0.77372298 |
| 71 | CAMK1 | 0.75208863 |
| 72 | ERBB3 | 0.74879781 |
| 73 | PNCK | 0.73145663 |
| 74 | SGK3 | 0.72995438 |
| 75 | DMPK | 0.72517321 |
| 76 | BCKDK | 0.71437717 |
| 77 | STK11 | 0.70446112 |
| 78 | TIE1 | 0.70355076 |
| 79 | TEC | 0.68579777 |
| 80 | RIPK1 | 0.67387964 |
| 81 | ALK | 0.63662033 |
| 82 | OXSR1 | 0.63635582 |
| 83 | CAMK2B | 0.60965091 |
| 84 | PRKCE | 0.60469559 |
| 85 | RPS6KA2 | 0.59907746 |
| 86 | CCNB1 | 0.58912200 |
| 87 | CAMK1G | 0.58412439 |
| 88 | FYN | 0.57695343 |
| 89 | PRKCZ | 0.57629251 |
| 90 | PRKG1 | 0.57516985 |
| 91 | WNK1 | 0.57374969 |
| 92 | SGK1 | 0.57238703 |
| 93 | GRK7 | 0.57220723 |
| 94 | MAP3K13 | 0.56057538 |
| 95 | TNK2 | 0.50173365 |
| 96 | CAMK2G | 0.50087755 |
| 97 | MAPK12 | 0.49874678 |
| 98 | MAPKAPK5 | 0.49555362 |
| 99 | CDC42BPA | 0.49249060 |
| 100 | MAP3K1 | 0.48841672 |
| 101 | PRKACA | 0.48351000 |
| 102 | PKN1 | 0.47575706 |
| 103 | SCYL2 | 0.47228110 |
| 104 | FGFR2 | 0.47054292 |
| 105 | PDK1 | 0.47035106 |
| 106 | WNK3 | 0.46114713 |
| 107 | CAMK2D | 0.46033854 |
| 108 | RAF1 | 0.45488774 |
| 109 | CAMK4 | 0.44395162 |
| 110 | TESK2 | 0.44257992 |
| 111 | PDPK1 | 0.43396175 |
| 112 | BCR | 0.42574665 |
| 113 | NEK1 | 0.42432295 |
| 114 | PTK2B | 0.42188071 |
| 115 | ROCK2 | 0.41489384 |
| 116 | PRKCA | 0.41136382 |
| 117 | RPS6KA3 | 0.40924785 |
| 118 | PRKCQ | 0.40749818 |
| 119 | PINK1 | 0.40672936 |
| 120 | PRKCB | 0.39732101 |
| 121 | CDK3 | 0.38770276 |
| 122 | OBSCN | 0.38742779 |
| 123 | MAPK10 | 0.38011004 |
| 124 | MAP3K5 | 0.37436595 |
| 125 | CSNK1D | 0.36599642 |
| 126 | BMPR2 | 0.36542303 |
| 127 | MAP3K6 | 0.35818006 |
| 128 | CSNK1G3 | 0.34922960 |
| 129 | PRKACG | 0.34743124 |
| 130 | CSNK1A1 | 0.34715495 |
| 131 | PRKD1 | 0.33142772 |
| 132 | ADRBK1 | 0.31955307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.24487670 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.06841065 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.59802689 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.55247718 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52693221 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46286702 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37615227 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35479255 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.32384113 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22917279 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19738685 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.08423373 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98132472 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.96665157 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.88061671 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.80813552 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.80207829 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72133289 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67847997 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66479531 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.66011390 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65371324 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.62980231 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59014838 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.56960917 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51774520 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.40426548 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36795052 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34102408 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32431552 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.29782385 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.29307521 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29272635 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28767807 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24486585 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24270642 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19222908 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.14237471 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14075732 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.11562269 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08719297 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04521791 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03549418 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03136559 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97692311 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96512884 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92934792 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.90243538 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89624488 |
| 50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88805604 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84142586 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83457543 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81091955 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81047330 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79765020 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78225866 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78113943 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77480302 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76817219 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75821397 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75751980 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74377720 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74193421 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74113194 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73689719 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71882045 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71278315 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.70898113 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70808858 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70178042 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69139578 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67281308 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67178005 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66237363 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64891527 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63702109 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63110515 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62274719 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62146974 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61725173 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60927181 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57950837 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56548601 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56397198 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56066265 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55007511 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54438619 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53822569 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53764572 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52215091 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51592654 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51536950 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50616930 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50389561 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50371748 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.50360006 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50124795 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50040600 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48683937 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48651468 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47970586 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46975403 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46773216 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45629885 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44865717 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44221908 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42666070 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42358395 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41436205 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40284654 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40044075 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37870811 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37203953 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36868329 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35686814 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.35058838 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.34036990 |
| 118 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33673286 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.28841846 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28671393 |
| 121 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.23387704 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23163414 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22267035 |

